(Q46489948)

22 December 2017

title

Diagnostic performance of the biomarkers HE4 and CA125 in type I and type II epithelial ovarian cancer (English)

1 reference

22 December 2017

1 reference

1 reference

Björg Kristjansdottir

1

1 reference

22 December 2017

Kristina Levan

2

1 reference

22 December 2017

Karolina Partheen

3

1 reference

22 December 2017

Karin Sundfeldt

4

1 reference

22 December 2017

language of work or name

English

0 references

publication date

25 July 2013

1 reference

22 December 2017

published in

Gynecologic Oncology

1 reference

22 December 2017

volume

131

1 reference

22 December 2017

issue

1

1 reference

22 December 2017

page(s)

52-58

1 reference

22 December 2017

New insights into ovarian cancer pathology.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.07.094

Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: Evidence for a causal relationship.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.07.094

Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.07.094

The fallopian tube-peritoneal junction: a potential site of carcinogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.07.094

Early detection of ovarian cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.07.094

Diverse tumorigenic pathways in ovarian serous carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.07.094

The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.07.094

Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer--shifting the paradigm

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.07.094

Integrated genomic analyses of ovarian carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.07.094

Metastatic patterns at autopsy in patients with ovarian carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.07.094

Evaluation of ovarian cancer biomarkers HE4 and CA-125 in women presenting with a suspicious cystic ovarian mass

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.07.094

The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.07.094

A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.07.094

Human epididymis protein 4 (HE4) plays a key role in ovarian cancer cell adhesion and motility

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.07.094

The new face of ovarian cancer modeling: better prospects for detection and treatment.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.07.094

The preclinical natural history of serous ovarian cancer: defining the target for early detection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.07.094

Comparison of candidate serologic markers for type I and type II ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.07.094

Role of histological type on surgical outcome and survival following radical primary tumour debulking of epithelial ovarian, fallopian tube and peritoneal cancers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.07.094

A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.07.094

Pathology of stage I versus stage III ovarian carcinoma with implications for pathogenesis and screening

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.07.094

HE4 and CA125 as a diagnostic test in ovarian cancer: prospective validation of the Risk of Ovarian Malignancy Algorithm

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.07.094

Evaluation of HE4, CA125, risk of ovarian malignancy algorithm (ROMA) and risk of malignancy index (RMI) as diagnostic tools of epithelial ovarian cancer in patients with a pelvic mass

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.07.094

Systematic evaluation of candidate blood markers for detecting ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.07.094

Human epididymis protein 4 (HE4) is a secreted glycoprotein that is overexpressed by serous and endometrioid ovarian carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.07.094

p53 autoantibodies as potential detection and prognostic biomarkers in serous ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.07.094

Ovarian cancer screening with annual transvaginal sonography: findings of 25,000 women screened.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.07.094

Mucinous but not clear cell histology is associated with inferior survival in patients with advanced stage ovarian carcinoma treated with platinum-paclitaxel chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.07.094

10.1016/J.YGYNO.2013.07.094

7 January 2021

Identifiers

DOI

1 reference

22 December 2017

1 reference

22 December 2017